CHROMOSOMAL POLYMORPHISMS INVOLVED IN REPRODUCTIVE FAILURE IN THE ROMANIAN POPULATION
Mierla D1,2*, Stoian V2
*Corresponding Author: Dana Mierla MD, Department of Genetics, Faculty of Biology, University of Bucharest, Bucharest, Romania; Tel.: +40721479083; E-mail: dana_mierla@yahoo.com
page: 23

RESULTS

Cytogenetic analysis revealed a number of numerical and structural abnormalities, but in this study only chromosomal polymorphisms involved in infertility are reported (Table 1). Chromosomal polymorphism were found in 122/1809 (6.74%) infertile patients in the study group and 63/1116 (5.65%) fetuses in the control group; this was not statistically significant (p = 0.24) (Figure1). The difference between the patients and controls for some specific chromosomal polymorphisms is statistically significant [e.g., inv(9), 1qh+, 9qh+, fra(17)]. This shows that there was a noteworthy relation at risk of infertility and polymorphic variants. The frequencies, according to our study, of the chromosomal polymorphisms for patients and controls are shown in Table 2. The most common variant observed in infertile couples was inv(9) (2.27%). Other chromosomal variants with a high incidence were 1qh+ (1.22%) and 9qh+ (1.11%). The least common polymorphic variations in infertile couples were usually observed in the para-centric heterochromatin on the long arms of chromosomes 16, 16qh+ (0.28%), the short-arm of the D and G groups of chromosomes 15ps+ (0.22), 21ps+ (0.33), 22ps+ (0.44%), and the distal heterochromatin of the Y chromosome, Yqh+ (0.16%). The frequency of heteromorphisms in females was 2.76% and 3.98% in males. Twenty males who had heteromorphisms were oligozoospermic or azoosper-mic. The seven women with chromosome heteromor-phisms had normospermic partners. As for the 1116 amniocentesis samples studied, we detected female karyotypes in 533 and male karyotypes in 583 fetuses. We observed polymorphisms in 63 fetuses (5.65%), 30 (1.65%) female and 33 (1.87%) male fetuses. The most frequent types of heteromorphisms in the control group were inv(9) at 3.76%, followed by 1qh+, 9qh+ and 16qh+ variants (0.36, 0.18 and 0.36%, respectively), followed by D and G group variants.



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006